Novartis AG
DOSAGE REGIMENS OF ANTI-LAG-3 ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
Dosage regimens for antibody molecules that specifically bind to LAG-3 are disclosed. The antibody molecules can be used to treat or prevent cancerous or infectious conditions and disorders.
Status:
Application
Type:
Utility
Filling date:
20 Jul 2018
Issue date:
4 Jun 2020